EPIRUS Biopharmaceuticals, Inc. Shareholders' Equity
EPIRUS Biopharmaceuticals, Inc. had Shareholders' Equity of $26.17 million as of 2016-03-31, per its 10-Q filed 2016-05-10.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2016-05-10
- 2016-03-31: Stockholders' Equity Attributable to Parent $26.17M.
- 2015-12-31: Stockholders' Equity Attributable to Parent $36.37M.
- 2015-09-30: Stockholders' Equity Attributable to Parent $50.70M.
- 2015-06-30: Stockholders' Equity Attributable to Parent $59.11M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2016-03-31 | $26.17M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $36.37M 10-Q · filed 2016-05-10 | |
| 2015-09-30 | $50.70M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $59.11M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $73.62M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $32.40M 10-K · filed 2016-03-29 | |
| 2014-09-30 | $42.40M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $14.31M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $10.66M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | -$39.38M 10-K · filed 2016-03-29 | $14.18M 10-K · filed 2014-03-14 |
| 2013-09-30 | $15.50M 10-Q · filed 2013-11-04 | |
| 2013-06-30 | $16.59M 10-Q · filed 2013-08-05 | |
| 2013-03-31 | $23.50M 10-Q · filed 2013-05-03 | |
| 2012-12-31 | -$21.19M 10-K · filed 2015-03-31 | $31.03M 10-K · filed 2013-03-07 |
| 2012-09-30 | $38.94M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $39.02M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $45.75M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $43.91M 10-K · filed 2014-03-14 | |
| 2011-09-30 | $53.95M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $62.54M 10-Q · filed 2011-08-04 | |
| 2010-12-31 | $63.00M 10-K · filed 2014-03-14 | |
| 2009-12-31 | $52.91M 10-K · filed 2013-03-07 | |
| 2008-12-31 | $15.88M 10-K · filed 2012-03-09 |